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1. Introduction 
The neurohypophyseal nonapeptide hormones, 
oxytocin and vasopressin are synthesized in specialized 
nuclei of the hypothalamus. They are translocated to 
the neurohypophysis, the storage and excretion organ, 
within membrane-limited secretory granules where 
they are found as non-covalent complexes with the 
10 000 mol. wt proteins, the neurophysins (reviewed 
[l-4]). The biogenesis of secretory protein com- 
ponents has been found to occur in the producing 
cells via larger biosynthetic precursors which generate 
the active molecules by post-translational processing. 
This appears to be the case for some peptide hormones 
[5-l 11. As early as 1964, classical experiments of 
in vivo pulse followed by in vitro chase allowed Sachs 
and coworkers to obtain evidence that the appearance 
of radioactively labeled, and active, Arg’-vasopressin 
(AVP) occurred after a lag period. Since this process 
was not inhibited by puromycin added during the 
chase, it was proposed that AVP was produced, first, 
as a larger inactive precursor molecule [ 12 ,I 31. So far 
this hypothesis has not been demonstrated. Analogous 
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methodology allowed similar conclusions with respect 
to neurophysin biogenesis, and a bifunctional pro- 
hormone, biosynthetic precursor common with AVP, 
was postulated [ 141. In connection with the search in 
the hypothalamus for higher molecular weight putative 
proneurophysins [ 1.5 ,161 we have analyzed the radio- 
immunoassayable forms of AVP in mouse hypo- 
thalamic extracts fractionated according to the appar- 
ent molecular size of their protein components. We 
show that higher molecular weight forms of AVP of 
> 30 000 and E 17 000 mol. wt can be detected 
together with the HMW neurophysinlike molecules 
of the corresponding apparent size. In addition, we 
show that a fraction of the immunoreactive species 
with - 17 000 mol. wt crossreact both with anti- 
neurophysin and anti-vasopressin antibodies. 
2. Materials and methods 
Phenylmethyl-sulfonylfluoride (PMSF), aprotinin, 
pepstatin, a-methyl-D-mannoside, bovine serum albu- 
mm were purchased from Sigma (St Louis, MO). 
Triton k-100 was from Calbiochem (San Diego, CA) 
and Bio-gel P-10 from Bio-Bad Laboratories 
(Richmond, CA). Insoluble concanavalin (con) 
A-Sepharose, Sephadex G-50 and activated 
CH-Sepharose 4B were supplied by Pharmacia 
(Uppsala). Human serum albumin (HSA) was from 
Behring (Marburg) and urea from Merck (Darmstadt). 
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Extraction and fractionation of mouse hypo- 
thalamic fragments were performed at 4°C. Hypo- 
thalamic fragments corresponding to the supraoptic 
and paraventricular nuclei of 50 mice were removed 
as in [ 151 and kept frozen in liquid nitrogen. Then 
the fragments were thawed and homogenized with a 
Potter Elvejhem in 5 ml 0.3 M sucrose containing 480 
kallikrein ~hibitor units (KIU)/ml aprotinin. The 
homogenate was centrifuged 1.5 min at 11 000 X g 
then the supernatant was collected and made 8 M in 
urea. The clear solution was centrifuged at 100 000 X g 
in a SW 50 rotor (Beckman L5 50) for 60 min and 
the supernatant was filtered on a Bio-gel P-10 column. 
The eluted fractions were tested for neurophysin and 
vasopressin immunoreactivities by a radioimmuno- 
assay procedure (RIA). 
The neurophysin RIA was carried out as in [ 151 
using an antiserum (AsIV) prepared by Dr Legros [ 171 
(Liege, Belgium) and in the presence of 480 KIU/ml 
aprotonin. Bovine neurophysin II and l2 ‘I-labeled 
bovine neurophysin II were used as standard and 
tracer respectively. The Arg*-vasopressin RIA was 
conducted as in [ 181, using antiserum Bert (l/45 000 
final dilution) and [’ 2 ’ I]AVP as tracer, allowing a 
minimal detection of 1-2 pg AVP. Under the condi- 
tions used 15% or 0.3% crossreactivity with Lys’vaso- 
pressin and oxytocin was observed. Less than 0.05% 
crossreactivity with neurophysin was detected. 
Affinity chromatography on con A-Sepharose 
was performed as in [ 151 using con A buffer (50 mM 
Tris-HCl containing 1 M NaCI, 1 mM CaClz, 1 mM 
MgClz, I mM MnCl, , 1 mgfml bovine serum albumin, 
1 o/00 Triton X-l 00,400 KIU/ml aprotinin (pH 7.5). 
Chromatography by immunoadsorption was with 
ammonium sulfate-precipitated anti-bovine neuro- 
physin II antibodies (SII 03) prepared in this labora- 
tory [19] and ~mmob~zed on CH-Sepharose 48 
using the procedure recommended by the manufac- 
turer. 
3. Results and discussion 
The pattern of the AVP-like material distributed 
in the eluate of the Bio-gel P-10 fractionation of the 
hypothalamic extracts made in 8 M urea allowed the 
detection of HMW forms of vasopressin (fig.1 A}. 
They were found to co-elute with the neurophysin- 
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like material both in the 17 000 mol. wt and exclu- 
sion p 20 000 mol. wt) volumes of the molecular 
sieve column (fig.1 A). The elution of urea rendered 
impossible the detection of free AVP by RIA. The 
Fig. 1. Immunological evidence for higher molecular weight 
forms of Arg*-vasopressin. (A) Gel filtration fractionation 
(Bio-gel P-10,40 X 4 cm column in 0.1 N HCOOH cont~ni~ 
0.1% Triton X-100,0.5 mM PMSF and 1 mg/l pepstatin) of 
the hypothalamic extracts. (B) Gel filtration (Bio-gel P-10, 
19 X 1.5 cm column equilibrated in the same eluent as 
above) of the 17 000 mol. wt species from (A) after expo- 
sure to 8 M urea for 16 h. (C) Sephadex G-50 fiRration 
(30 X 1.5 cm column equilibrated in the same eluent as 
above) of the material recovered in the I’o of the fractiona- 
tion from (A) after exposure to 8 M urea for 14 h. The 
AVP-like (A-A) and neurophysin-like (o-0) immunoreac- 
tivities were determined every two fractions by RIA. The 
materials eluted in the Vo of the Bio-gel P-10 and of the 
Sephadex G-50 correspond, respectively, to species with 
app. mol. wt > 20 000 and > 30 000. 
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elution profile of the AVP-like material recovered in 
the 17 000 mol. wt volume was not affected by 
exposure to 8 M urea (fig.1 B). This demonstrates 
that the 17 000 mol. wt material is neither AVP 
aggregates nor AVP non-covalently attached to 
larger components. The material recovered in the 
exclusion volume of the same molecular sieve filtra- 
tion (i.e., > 20 000 mol. wt) represents a relatively 
small fraction of the neurophysin immunoreactivity 
detected in the extracts (fig.lA). After exposure to 
8 M urea for 14 h, it was filtered on a Sephadex 
G-50 column. The elution pattern of fig.lC indicates 
that both neurophysin-like and AVP-like immuno- 
reactive materials co-eluted together in volumes 
suggesting species with mol. wt Z 30 000. Two dis- 
crete peaks of neurophysin-like material with sizes 
- 17 000 and 10 000 mol. wt, respectively, were 
observed (fig.lC) suggesting that these lower sized 
species were generated during the operations. These 
observations indicative of post-translational process- 
ing, will be detailed in [ 193. 
Control experiments were performed as in [20] in 
order to assess that both neurophysin-like and AVP- 
like immunoreactivities detected in the exclusion 
volume of the molecular sieve filtration are real. It 
was found that they neither reflect protease activities 
affecting the integrity of the l2 ‘I-labeled tracers nor 
are due to interference of other components in the 
RIA. This material was also tested for its ability to 
compete with the labeled neurophysin, or AVP, for 
binding to the corresponding antibodies. Serial dilu- 
tions of the 17 000 and 2 30 000 mol. wt materials 
gave characteristic plots (fig.2) suggesting unequiv- 
ocally antigenic similarities with the reference com- 
ponents used as standards. 
The 17 000 mol. wt neurophysin-like material 
(as in fig.lA) has been shown to exhibit strong inter- 
actions with a plant lectin, con A and can be selec- 
tively adsorbed on a covalent conjugate of the lectin 
(con A-Sepharose) [ 151. This property, characteristic 
of many other secretory protein components, is 
believed to reflect some degree of protein glycosyla- 
tion. It was therefore interesting to test for the 
possibility that the 17 000 mol. wt vasopressin-like 
material may carry carbohydrate moieties. The pat- 
tern of the experiment in fig.3 indicates that 90% of 
the 17 000 mol. wt neurophysin-like material was 
retained by the affinity adsorbant and was desorbed 
Fig.2. Immunological analysis of the AVP and neurophysin- 
like materials recovered in the 17 000 mol. wt (-¤-) and 
exclusion (-+-) volumes of the Bio-gel P-10 fractionation 
of fig.lA. Serial dilutions of the material to be analyzed 
were evaluated for their capacity to compete with 1251- 
labeled neurophysin or [ 1 *51]AVP for binding to the cor- 
responding antibodies. Immunoreactivities of the dilutions 
are expressed as AVP, or neurophysin, equivalents respec- 
tively calculated from corresponding standard curves (pg 
and ng per assay). 
by irrigation of the con A-Sepharose conjugate 
successively by 0.2 M and 1 M cr-methyl-mannoside. 
In contrast, the totality of the AVP-like material 
was not retained and was recovered, together with 
10% of the neurophysin-like immunoreactivity, in 
the void volume of the affinity column. This obser- 
vation might be taken as suggestive that while most 
of the 17 000 mol. wt neurophysin-like material is 
ml 
Fig.3. Affinity chromatography on a con A-Sepharose 
adsorbant of the 17 000 mol. wt immunoreactive material 
from fig.lA. The lyophilized sample was dissolved in the 
con A buffer and adsorbed on the column equilibrated in 
the same buffer. The column was then washed with the 
same buffer (A) then with 0.2 M (B) and 1.0 M (C) 
a-methyl-mannoside in con A buffer. AVP-like (A-A) and 
neurophysin (N )-lie (o-o) immunoreactivities were 
measured by R A on each fraction. P 
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Fig.4. Affinity chromatography on anti-bovine neurophysin 
II antibodies immobilized on CH-Sepharose 4B. The 
17 000 mol. wt material from fii. 1 A was lyophilized and 
applied on the cokmn in tOO mM phosphate buffer, 
100 mM NaC1,O.l HSA mg/ml (pII 7.5). The complex was 
washed (A) with the same buffer then with a 10 mM phos- 
phate buffer (pW 7.5) (B) and desorption was conducted 
(C) by 1 M acetic acid. Both AVP (A-A.) and neurophysin 
(Np) (0-o) in~nlunoreact~vities w re measured every 2 frac- 
tions (0.5 ml). 
glycosylated to various extents, the 17 000 mol. wt 
material AVP-like is not. The latter may be substi- 
tuted with other carbohydrate moieties which do 
not exhibit interactions with the eon A immobilized 
on Sepharose . 
It was interesting, however, to check if the AVP- 
like molecules carry also the neurophysin deter” 
minants in their sequence. The 17 000 mol. wt 
material (from fig.lA) was submitted to an affinity 
&hromatogra~hy by ~mmunoadsorption on a 
Sepharose ---ant~neurophysin mmune serum covalent 
conjugate. The pattern in fig.4 indicates clearly that 
a fraction of the original AVP-like material applied 
to the column was coadsorbed with 90% of the origi- 
nal neurophysin-like species and was desorbed only 
by a drastic pH change*. Control experiments showed 
that the jInmunoadsorbent retained < 1 S% of 
[‘251JAVP or G 5% of standard AVP as detected by 
RIA. 
+ Significant amounts of AVP-like immunoreactivity were 
recovered in the washing volume of the column (fig.4). 
Observations (not shown) indicate that the material respon- 
sible for this immunoreactivity is smalkr than the species 
applied to the column and may correspond to fragments 
bearing the AVP sequence and derived by proteolytic 
cleavage of the larger molecules during the affinity chro- 
matography procedure [ 191 
These observations, together with the analysis of 
the experiment on con A-Sepharose (fig.?), strongly 
suggest hat a small proportion of the 17 000 mol. wt 
immunoreactive species may carry both the AVP and 
neurophysin antigenic determinants in their sequence. 
Furthermore the elution behaviour of the immuno- 
reactive material recovered in the exclusion volume 
of the Bio-gel P-10 fractionation, after filtration on 
Sephadex G-50 clearly indicates that both AVP-like 
and neurophysin-like immunoreactivities co-elute in 
the exclusion volume (i.e., > 30 000 mol. wt) (fig.1 C). 
This is compatible with the existence of larger high 
molecular weight immunoreactive forms of neuro- 
physin and AVP Q 30 000 mol. wt) in the mouse 
hypothalamus. Consequently it is attractive to postu- 
late that the intermediary size material (the 17 000 
mol. wt neurophysin-like glycosylated species and 
the 17 000 mol. wt fneurophysin-AVP]-like hybrid 
molecules) may derive from the larger species by a 
post-tr~s~ation~ process invoking heterolytic 
cleavage. However a pulse-labeled 20 000 mol. wt, 
neurophysin-like material has been synthesized in 
the rat [21]. Neurophysin-containing molecules of 
25 000 mol. wt [22] and 17 000 mol. wt [23] have 
been reported in the imm~opre~ipitabie compo- 
nents of the cell-free translation products of hypo- 
thalamic mRNA from bovine ]22] and rat or mouse 
[23], respectively. Although relationships with AVP- 
like higher molecular weight forms were nat analyzed 
in [21-231 these forms may be comparabfe to the 
corresponding species described above and in [ 15,161. 
The immunorea~ti~e formsofa 30 000 mol. wt could 
represent putative biosynthetic precursors common 
both to neurophysin and AVP. Because of the dif- 
ficulties in obtaining reasonable amounts of the 
larger immunoreactive forms from the mouse hypo- 
thalamus this hypothesis will be investigated on 
sources from other species [to]. 
Acknowledgements 
This work was supported in part by grants from 
the Universite Pierre et Marie Curie, the Centre 
National de la Recherche Scientifique (Equipe de 
Recherches Associee no. 693), the Fondation pour 
la Recherche Medicale Franqaise and the &legation 
a la Recherche Scientifique et Technique (contrat 
372 
Volume 108. number 2 FEBS LETTERS December 1979 
no. 79-7-0788). The support of the Departement 
de Biologie du Centre d’Etudes Nuclkaires, Saclay, 
with the supply of radiochemicals and a doctoral 
fellowship to M.L. is greatly appreciated. 
References 
[I] Walter, R. (19’75) Ann. NY Acad. Sci. 248, 1-512. 
[2] Pickering, B. T. and Jones, C. W. (1978) in: Hormonal 
Proteins and Peptides (Li, C. H, ed) vol. 5, pp. 
103-158, Academic Press, New York. 
[ 31 Breslow, E. (1979) Ann. Rev. Biochem. 48, 25 l-274. 
(4) Cohen, P., Nicolas, P. and Camier, M. (1979) Curr. Top. 
Cell. Reg. IS, in press. 
151 Steiner, D. F. and Oyer, P. E. (1967) Proc. Natl. Acad. 
Sci. USA 57,473-480. 
[6] Kemper, B., Habener, J. F., Potts, J. T. and Rich, A. 
(1972) Proc. Natl. Acad. Sci. USA 69, 643-647. 
[7] Cohn, D. V., MacGregor, R. R., Chu, L. L. H., Kimmel, 
J. R. and Hamilton, J. W. (1972) Proc. Natl. Acad. Sci. 
USA 69,1521-1525. 
[S] Sussman, P. M., Tushinski, R. J. and Bancroft, F. C. 
(1976) Proc. Natf. Acad. Sci. USA 73, 29-33. 
[9] Mains, R. E., Eipper, B. A. and Ling, N. (1977) 
Proc. Natl. Acad. Sci. USA 74, 301443018. 
[IO] Roberts, J. L. and Herbert, E. (1977) Proc. Natl. Acad. 
Sci. USA 74,5300-5304. 
[ 111 Lauber, M., Camier, M. and Cohen, P. (1980) Proc. 
Natl. Acad. Sci. USA, in press. 
[ 121 Sachs, H. and Takabatake, Y. (1964) endocrinology 
75,943-948. 
[13] Takabatake, Y. and Sachs, H. (1964) Endocrinology 
75,934-942. 
[14] Fawcett, C. P., Powell, A. E. and Sachs, H. (1968) 
Endocrinology 83,1299-1310. 
[ 1.51 Lauber, M., Camier, M. and Cohen, P. (1979) 
FEBS Lett. 97, 343-347. 
1161 Lauber, M., Camier, M., Masse, M. J. 0. and Cohen, P. 
(1980) Biologie Cellultie, in press. 
[ 171 Legros, J. J. and Franchimont, P. (1974) Ann. Endocr. 
Paris 3.5, 189-194. 
[ 181 Miihring, B. and Miihring, J. (1975) Life Sci. 17, 
1307-1314. 
[ 191 Nicolas, P., Camier, M., Lauber, M., Miihring, J. and 
Cohen, P. (1980) in preparation. 
[ 201 Straus, E. and Yalow, R. S. (1977) in: Peptides in 
Neurobiology (Gainer, H. ed) pp. 39-60, Plenum Press, 
New York. 
[21] Gainer, H., Same, Y. and Brownstein, M. J. (1977) 
Science 19.5,1354-1356. 
[ 221 Giudice, L. C. and Chaiken, I. M. (1979) Proc. Natl. 
Acad. Sci. USA 76, 3800-3804. 
1231 Lin, C., Joseph-Bravo, P., Sherman, T., Ghan, L. and 
MacKelvy, J. F. (1979) Biochem. Biophys. Res. 
Commun. 89,943-950. 
373 
